POLR2J | OmnibusX

I. Expression across cell types

Name	Number of supported studies	Average coverage
natural killer cell	25 studies	26% ± 9%	Explore
fibroblast	23 studies	27% ± 10%	Explore
endothelial cell	21 studies	27% ± 12%	Explore
B cell	20 studies	28% ± 10%	Explore
CD4-positive, alpha-beta T cell	20 studies	25% ± 8%	Explore
T cell	19 studies	23% ± 8%	Explore
smooth muscle cell	19 studies	25% ± 6%	Explore
CD8-positive, alpha-beta T cell	19 studies	27% ± 8%	Explore
classical monocyte	18 studies	27% ± 12%	Explore
non-classical monocyte	17 studies	30% ± 16%	Explore
pericyte	17 studies	27% ± 7%	Explore
regulatory T cell	17 studies	25% ± 6%	Explore
conventional dendritic cell	16 studies	29% ± 15%	Explore
macrophage	16 studies	27% ± 10%	Explore
epithelial cell	14 studies	38% ± 20%	Explore
ciliated cell	13 studies	38% ± 17%	Explore
gamma-delta T cell	13 studies	25% ± 14%	Explore
monocyte	12 studies	28% ± 7%	Explore
plasma cell	11 studies	30% ± 12%	Explore
basal cell	11 studies	31% ± 17%	Explore
mature NK T cell	11 studies	26% ± 6%	Explore
connective tissue cell	11 studies	27% ± 10%	Explore
memory B cell	10 studies	21% ± 3%	Explore
CD16-positive, CD56-dim natural killer cell, human	10 studies	27% ± 8%	Explore
naive thymus-derived CD4-positive, alpha-beta T cell	10 studies	21% ± 5%	Explore
endothelial cell of lymphatic vessel	9 studies	28% ± 10%	Explore
CD8-positive, alpha-beta memory T cell	9 studies	24% ± 10%	Explore
naive B cell	9 studies	21% ± 4%	Explore
naive thymus-derived CD8-positive, alpha-beta T cell	9 studies	26% ± 7%	Explore
abnormal cell	9 studies	30% ± 14%	Explore
plasmacytoid dendritic cell	9 studies	27% ± 10%	Explore
dendritic cell	8 studies	40% ± 26%	Explore
club cell	7 studies	27% ± 11%	Explore
secretory cell	7 studies	26% ± 14%	Explore
CD16-negative, CD56-bright natural killer cell, human	7 studies	27% ± 7%	Explore
myofibroblast cell	7 studies	28% ± 7%	Explore
mucosal invariant T cell	7 studies	21% ± 5%	Explore
endothelial cell of vascular tree	7 studies	20% ± 4%	Explore
myeloid cell	7 studies	27% ± 13%	Explore
plasmablast	6 studies	44% ± 21%	Explore
CD4-positive, alpha-beta memory T cell	6 studies	27% ± 5%	Explore
capillary endothelial cell	6 studies	22% ± 6%	Explore
progenitor cell	6 studies	29% ± 14%	Explore
endothelial cell of artery	6 studies	24% ± 6%	Explore
goblet cell	6 studies	29% ± 15%	Explore
vein endothelial cell	6 studies	24% ± 10%	Explore
innate lymphoid cell	6 studies	21% ± 2%	Explore
effector CD8-positive, alpha-beta T cell	5 studies	26% ± 6%	Explore
leukocyte	5 studies	28% ± 10%	Explore
effector memory CD8-positive, alpha-beta T cell	5 studies	30% ± 10%	Explore
kidney loop of Henle epithelial cell	5 studies	26% ± 2%	Explore
epithelial cell of proximal tubule	5 studies	27% ± 6%	Explore
enterocyte	5 studies	23% ± 6%	Explore
mesothelial cell	5 studies	32% ± 15%	Explore
precursor B cell	5 studies	32% ± 11%	Explore
type II pneumocyte	5 studies	33% ± 17%	Explore
T follicular helper cell	5 studies	23% ± 3%	Explore
hematopoietic precursor cell	4 studies	39% ± 19%	Explore
mononuclear phagocyte	4 studies	30% ± 16%	Explore
exhausted T cell	4 studies	32% ± 12%	Explore
kidney distal convoluted tubule epithelial cell	4 studies	37% ± 4%	Explore
erythroblast	4 studies	35% ± 23%	Explore
pro-B cell	4 studies	31% ± 9%	Explore
neuron	4 studies	31% ± 20%	Explore
mast cell	4 studies	17% ± 2%	Explore
effector memory CD4-positive, alpha-beta T cell	4 studies	30% ± 10%	Explore
T-helper 17 cell	4 studies	25% ± 6%	Explore
deuterosomal cell	3 studies	21% ± 4%	Explore
duct epithelial cell	3 studies	19% ± 3%	Explore
ionocyte	3 studies	24% ± 5%	Explore
pancreatic A cell	3 studies	41% ± 15%	Explore
type B pancreatic cell	3 studies	37% ± 16%	Explore
glomerular endothelial cell	3 studies	18% ± 1%	Explore
renal alpha-intercalated cell	3 studies	35% ± 3%	Explore
neural crest cell	3 studies	33% ± 5%	Explore
transit amplifying cell	3 studies	18% ± 2%	Explore
lymphocyte	3 studies	32% ± 12%	Explore
megakaryocyte	3 studies	18% ± 1%	Explore
type I pneumocyte	3 studies	38% ± 11%	Explore
alveolar macrophage	3 studies	17% ± 0%	Explore
intraepithelial lymphocyte	3 studies	26% ± 7%	Explore
Mueller cell	3 studies	25% ± 7%	Explore
erythrocyte	3 studies	34% ± 21%	Explore
germinal center B cell	3 studies	27% ± 5%	Explore
effector CD4-positive, alpha-beta T cell	3 studies	23% ± 3%	Explore
intermediate monocyte	3 studies	39% ± 18%	Explore
oligodendrocyte precursor cell	3 studies	27% ± 7%	Explore
neutrophil	3 studies	16% ± 0%	Explore
enteroendocrine cell	3 studies	38% ± 19%	Explore
hepatocyte	3 studies	43% ± 32%	Explore
T-helper 1 cell	3 studies	25% ± 0%	Explore
effector memory CD8-positive, alpha-beta T cell, terminally differentiated	3 studies	21% ± 3%	Explore

II. Expression across tissues

Name	Number of supported studies	Average coverage
lung	13 studies	29% ± 12%	Explore
peripheral blood	12 studies	29% ± 10%	Explore
intestine	9 studies	25% ± 12%	Explore
kidney	7 studies	23% ± 5%	Explore
liver	6 studies	28% ± 21%	Explore
bone marrow	4 studies	20% ± 4%	Explore
uterus	4 studies	30% ± 17%	Explore
lymph node	4 studies	26% ± 7%	Explore
brain	4 studies	23% ± 7%	Explore
pancreas	3 studies	38% ± 16%	Explore
eye	3 studies	28% ± 9%	Explore
breast	3 studies	20% ± 4%	Explore

Tissue	GTEx Coverage	GTEx Average TPM	GTEx Number of samples	TCGA Coverage	TCGA Average TPM	TCGA Number of samples
adrenal gland	100%	2203.62	258 / 258	100%	107.12	230 / 230
brain	100%	1646.95	2642 / 2642	100%	138.35	705 / 705
esophagus	100%	1493.06	1445 / 1445	100%	90.56	183 / 183
liver	100%	1422.03	226 / 226	100%	90.89	406 / 406
ovary	100%	1523.71	180 / 180	100%	162.62	430 / 430
pancreas	100%	873.69	328 / 328	100%	82.61	178 / 178
skin	100%	1548.89	1809 / 1809	100%	110.97	472 / 472
thymus	100%	1663.82	653 / 653	100%	104.20	605 / 605
uterus	100%	1360.49	170 / 170	100%	115.89	459 / 459
kidney	100%	1688.82	89 / 89	99%	81.29	896 / 901
intestine	100%	1540.44	966 / 966	99%	100.67	524 / 527
stomach	100%	1331.62	359 / 359	99%	100.75	284 / 286
prostate	100%	1742.32	245 / 245	99%	105.03	498 / 502
breast	100%	1431.47	459 / 459	99%	85.67	1106 / 1118
bladder	100%	1420.24	21 / 21	99%	112.60	498 / 504
lung	99%	1251.11	575 / 578	99%	92.75	1144 / 1155
adipose	100%	1410.99	1204 / 1204	0%	0	0 / 0
eye	0%	0	0 / 0	100%	88.29	80 / 80
lymph node	0%	0	0 / 0	100%	151.95	29 / 29
muscle	100%	2876.81	803 / 803	0%	0	0 / 0
spleen	100%	1649.02	241 / 241	0%	0	0 / 0
tonsil	0%	0	0 / 0	100%	90.77	45 / 45
ureter	0%	0	0 / 0	100%	130.73	1 / 1
heart	100%	1854.30	860 / 861	0%	0	0 / 0
blood vessel	100%	1434.83	1333 / 1335	0%	0	0 / 0
peripheral blood	100%	1596.13	927 / 929	0%	0	0 / 0
abdomen	0%	0	0 / 0	0%	0	0 / 0
bone marrow	0%	0	0 / 0	0%	0	0 / 0
diaphragm	0%	0	0 / 0	0%	0	0 / 0
gingiva	0%	0	0 / 0	0%	0	0 / 0
nasal cavity	0%	0	0 / 0	0%	0	0 / 0
nasopharynx	0%	0	0 / 0	0%	0	0 / 0
nose	0%	0	0 / 0	0%	0	0 / 0
placenta	0%	0	0 / 0	0%	0	0 / 0
spinal column	0%	0	0 / 0	0%	0	0 / 0

III. Associated gene sets

GO_0006366	Biological process	transcription by RNA polymerase II
GO_0005665	Cellular component	RNA polymerase II, core complex
GO_0005654	Cellular component	nucleoplasm
GO_0005634	Cellular component	nucleus
GO_0003677	Molecular function	DNA binding
GO_0001055	Molecular function	RNA polymerase II activity
GO_0046983	Molecular function	protein dimerization activity
GO_0005515	Molecular function	protein binding
GO_0030275	Molecular function	LRR domain binding
GO_0003899	Molecular function	DNA-directed 5'-3' RNA polymerase activity

IV. Literature review

[source]

Gene name	POLR2J
Protein name	DNA-directed RNA polymerase II subunit RPB11-a (RNA polymerase II subunit B11-a) (RPB11a) (DNA-directed RNA polymerase II subunit J-1) (RNA polymerase II 13.3 kDa subunit)
Synonyms	POLR2J1
Description	FUNCTION: Core component of RNA polymerase II (Pol II), a DNA-dependent RNA polymerase which synthesizes mRNA precursors and many functional non-coding RNAs using the four ribonucleoside triphosphates as substrates. .
Accessions	P52435 ENST00000292614.10

POLR2J report

I. Expression across cell types

II. Expression across tissues

III. Associated gene sets

IV. Literature review